Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis

Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis

Zongbei Yang,1,2 Jing Wang,2 Zhenlin Zhang,1 Faqing Tang2 1Zhuhai People’s Hospital, Zhuhai Hospital of Jinan University, Zhuhai, People’s Republic of China; 2Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsh...

Full description

Bibliographic Details
Main Authors:	Yang Z, Wang J, Zhang Z, Tang F
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-01-01
Series:	OncoTargets and Therapy
Subjects:	nasopharyngeal carcinoma circulating tumor cell metastasis epstein-barr virus
Online Access:	https://www.dovepress.com/epstein-barr-virus-encoded-products-promote-circulating-tumor-cell-gen-peer-reviewed-article-OTT

Similar Items

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
by: Ai-Di Gu, et al.
Published: (2012-10-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01)

Nasopharyngeal carcinoma with pericardial metastasis
by: Shang-Wen Chen, et al.
Published: (2011-07-01)

Circulating cell‐free epstein–barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma
by: Amina Gihbid, et al.
Published: (2021-02-01)

Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
by: Rong Tan, et al.
Published: (2020-11-01)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
by: Ting Hu, et al.
Published: (2019-05-01)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01)

Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
by: Banko Ana, et al.
Published: (2014-01-01)

Analysis of Serum Levels of IgA Antibodies to Epstein Barr Virus Capsid Antigens in the Spouses and the Children of Patients with Nasopharyngeal Carcinoma
by: Jiru CHENG, et al.
Published: (2009-08-01)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
by: Chin King Looi, et al.
Published: (2021-04-01)

The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration
by: Hannah E. Bridgewater, et al.
Published: (2020-07-01)

Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
by: Rob J. A. Verhoeven, et al.
Published: (2019-10-01)

CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
by: Wang ZH, et al.
Published: (2020-04-01)

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
by: Ting Zhou, et al.
Published: (2019-08-01)

Immunological response of patients with nasopharyngeal carcinoma against Epstein-Barr virus-specific antigens.
Published: (2004)

Characterization of aberrantly expressed microRNAs in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Published: (2013)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
by: Sai-Lan Liu, et al.
Published: (2020-02-01)

Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
by: Guoping Ou, et al.
Published: (2019-11-01)

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma
by: Guo, Q., et al.
Published: (2022)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
by: Chung-Chun Wu, et al.
Published: (2018-04-01)

Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
by: Jian Zhang, et al.
Published: (2018-12-01)

Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas
by: Wang Xinying, et al.
Published: (2012-02-01)

Expression of Epstein-Barr virus proteins and their detection by IgG antibodies
by: Rosek, Alyssa
Published: (2018)

Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma
by: Ji-Jin Yao, et al.
Published: (2017-12-01)

Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma
by: Qiao Li, et al.
Published: (2021-03-01)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
by: Lingzhi Liu, et al.
Published: (2019-06-01)

Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
by: Richmond Ayee, et al.
Published: (2020-07-01)

Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA
by: Chen-Fei Wu, et al.
Published: (2021-08-01)

Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: Study design, methods and feasibility
by: Guo Xiu, et al.
Published: (2006-06-01)

DNA Epstein-Barr virus (EBV) sebagai biomaker diagnosis karsinoma nasofaring
by: Janti Sudiono, et al.
Published: (2013-09-01)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
by: Lisheng Zhu, et al.
Published: (2021-09-01)

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
by: Yongqiao He, et al.
Published: (2021-08-01)

Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy
by: Wen-Fei Li, et al.
Published: (2017-11-01)

Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma
by: Shaina Chor Mei Huang, et al.
Published: (2018-04-01)

Nasopharyngeal Carcinoma Associated with Hemophagocytic Lymphohistiocytosis
by: Hsu Wu, et al.
Published: (2015-03-01)

Progesterone analogues reduce plasma Epstein–Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care
by: Chia-Yen Hung, et al.
Published: (2017-08-01)

Cannot write session to /tmp/vufind_sessions/sess_pfo3mavglhhdb9avts7mlphif1